- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Uncontrolled Essential Hypertension in Hong Kong
Total 177 results
-
United TherapeuticsTerminatedPulmonary Hypertension | Interstitial Lung Disease | Combined Pulmonary Fibrosis and EmphysemaUnited States, Puerto Rico
-
Boehringer IngelheimCompleted
-
United TherapeuticsCompletedPulmonary Hypertension | Interstitial Lung Disease | Combined Pulmonary Fibrosis and EmphysemaUnited States, Puerto Rico
-
Boehringer IngelheimCompletedHypertensionUnited States, Canada
-
Boehringer IngelheimCompleted
-
VA Office of Research and DevelopmentCompleted
-
Boehringer IngelheimCompletedHypertensionUnited States, Bulgaria, Czech Republic, France, Hungary, Korea, Republic of, Romania, Russian Federation, Slovakia, Spain, Ukraine
-
AllerganCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedHypertensionUnited States, Argentina, Korea, Republic of, Mexico, Netherlands, Slovakia, South Africa, Spain, Sweden
-
Boehringer IngelheimCompletedHypertensionUnited States, Argentina, Brazil, Mexico, South Africa
-
Forest LaboratoriesCompletedHypertensionUnited States
-
Theravance BiopharmaCompletedSymptomatic Neurogenic Orthostatic HypotensionUnited States, Spain, Israel, Hungary, Portugal, Australia, Canada, Germany, Russian Federation, Estonia, France, Italy, United Kingdom, Denmark, Poland, New Zealand, Austria, Bulgaria, Ukraine
-
Bristol-Myers SquibbSanofiCompletedHypertensionUnited States, Canada, Germany, Russian Federation, France
-
Boehringer IngelheimCompletedHypertensionUnited States, Argentina, Canada, Chile, Mexico, Peru
-
Daiichi Sankyo, Inc.Completed
-
Alnylam PharmaceuticalsActive, not recruitingHypertensionUnited States, Canada, Latvia, Poland, United Kingdom, Germany, Lithuania, Estonia, Puerto Rico
-
AbbVieRecruiting
-
Daiichi Sankyo, Inc.CompletedHypertensionUnited States, Puerto Rico
-
Bristol-Myers SquibbSanofiCompletedHypertensionUnited States, Belgium, Canada, Germany, Russian Federation, France, Israel, Netherlands
-
GlaxoSmithKlineCompletedHypertensionUnited States
-
Boehringer IngelheimEli Lilly and CompanyCompletedHypertension | Diabetes Mellitus, Type 2United States
-
Forest LaboratoriesCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompletedHypertension | Diabetes Mellitus, Type 2United States, Canada, Czech Republic, Denmark, Estonia, Finland, France, Germany, Lebanon, Netherlands, Norway, Sweden
-
Boehringer IngelheimCompletedHypertension | Diabetes Mellitus, Type 2Taiwan, Korea, Republic of, United States, New Zealand, Australia, Argentina, Canada, Mexico
-
KBP BiosciencesActive, not recruitingChronic Kidney DiseasesChina, Spain, Australia, Hungary, Malaysia, United States, Germany, Bulgaria, Serbia, Hong Kong, Georgia, Bosnia and Herzegovina, Croatia, Czechia, South Africa, Canada, Israel, Korea, Republic of, Latvia, Lithuania, Poland, Taiwan
-
AstraZenecaRecruitingChronic Kidney Disease and HypertensionSpain, United States, Argentina, Denmark, Italy, Sweden, United Kingdom, Belgium, France, Turkey, China, Germany, Saudi Arabia, Thailand, Vietnam, Australia, Serbia, Brazil, Canada, Japan, Malaysia, Philippines, Poland, Taiwan, Greece, Is... and more